Home > Newsroom > News Archive
The articles listed in the Cancer Center's News Archive are here for historical purposes. The information and links may no longer be
Ann Arbor - Today, the
CDC's Advisory Committee on Immunization Practices
recommended to give Gardasil – a vaccine designed to
provide protection against human papillomavirus, or HPV, the
virus linked to cervical cancer – as a routine vaccination
to girls ages 11 and 12, and as a catch-up vaccine for women
ages 13 to 26. The group also said that girls as young as
9 could receive the vaccine, at the discretions of their health
University of Michigan Health System experts – including
one who is the chair of the ACIP’s HPV Working Group
– are available to discuss these recommendations and
recent research about HPV vaccines, as well as provide information
about cervical cancer, HPV and childhood immunizations.
ACIP vaccine recommendations: U-M expert in Atlanta
Janet Gilsdorf, M.D., Director, Pediatric Infectious Diseases
and Immunology at the U-M C.S. Mott Children’s Hospital,
and chair of the HPV Working Group for the CDC's Advisory Committee on Immunization Practices.
- As a voting member of the ACIP, Gilsdorf helped to
draft the age and gender recommendations for use of Gardasil.
From today’s meeting in Atlanta, Gilsdorf can discuss
how and why the ACIP made certain recommendations for use
of Gardasil, and her role as chair of the HPV Working Group.
- Gilsdorf, professor of pediatrics and communicable
diseases and professor of epidemiology, also is co-director
for the Center for Molecular and Clinical Epidemiology of
Infectious Diseases at the U-M School of Public Health. Her
research interests include vaccine development.
U-M study: Will parents accept new HPV
vaccines for kids?
Amanda F. Dempsey, M.D., Ph.D., MPH, lecturer
in the Division of General Pediatrics at the U-M Medical School
and a member of the Child Health Evaluation and Research (CHEAR)
Unit in the Division of General Pediatrics at Mott.
- In a recent study published in the journal Pediatrics,
Dempsey found that providing parents with general information
about HPV and HPV vaccines is not enough to influence their
decision to vaccinate their young children against HPV. The
study revealed parental beliefs about the benefits of HPV
vaccinations are instead driven by their feelings about vaccinations;
the opinions of their peers and doctors; and their personal
experiences with sexually transmitted diseases or HPV-related
Experts: HPV and Cervical Cancer
Anthony Opipari, M.D., Ph.D., assistant professor of obstetrics and gynecology at the U-M Medical School and a member of the
U-M Comprehensive Cancer Center.
- Opipari sees patients with abnormal Pap smears and diseases of the cervix, vagina and vulva related to HPV infection.
His research interests are in HPV detection methods.
For more information, contact:
Return to top
Return to top